University of Pennsylvania
Open enrollment with an early-phase pipeline tilt
According to ClinicalTrials.gov-derived indexes, University of Pennsylvania sits in the top decile of US sponsors by registered trial count (#15 of 15,751 sponsors by registered trial count).
University of Pennsylvania: 1,423 sponsored US clinical trials, 199 recruiting.
University of Pennsylvania sponsors 1,423 registered US clinical trials on ClinicalTrials.gov, 199 of them currently recruiting, and 982 completed. 130 of these trials are in Phase 3-4 (later-stage) and 339 in Phase 1-2 (earlier-stage). The most-studied condition in this pipeline is Obesity, with 17 trials.
Top-decile sponsor footprint
University of Pennsylvania ranks in the top decile of sponsors by registered trial count (#15 of 15,751 sponsors by registered trial count). Volume at this scale usually reflects a long institutional pipeline, read phase tilt and therapeutic areas below before treating it as current-year activity.
Open and recent trials
1,423 total, page 24 of 29
HBPL Study of the Impact of the NK1 Antagonist Aprepitant
NCT01176591
Smoking Topography and Harm Exposure in Menthol Cigarettes
NCT01329263
IMCgp100 in Advanced Unresectable Melanoma
NCT01209676
Allo CART-19 Protocol
NCT01551043
Pudendal Assessment in Erectile Dysfunction
NCT01262833
The PACE/PACENET Behavioral Health Laboratory Project
NCT02440594
Breast Cancer Prevention Education
NCT01299623
Sabril for Complex Partial Seizures in Adult Tolerability Study (TS) Patients
NCT01266291
African American Preference for Knee Replacement: A Patient-Centered Intervention
NCT01851785
Human Behavioral Pharmacology Laboratory (HBPL) Study of Varenicline's Impact on Cocaine and Alcohol Craving
NCT01151813
Alternative Sedation During Bronchoscopy
NCT01158820
Rhodiola Rosea Therapy of Major Depressive Disorder
NCT01098318
Plasma Exchange and Glucocorticoids for Treatment of Anti-Neutrophil Cytoplasm Antibody (ANCA) - Associated Vasculitis
NCT00987389
Decreasing the Incidence of Post-Operative Nausea and Vomiting (PONV) in Bariatric Patients
NCT00956215
Race and Preference for Knee Replacement: A Patient-Centered Intervention
NCT02413411
Using Technology to Promote Mental Acuity
NCT01126021
New Ways to Help Patients Improve Their Diabetes Control
NCT01143870
Brain Activity and Smoking Cessation
NCT01186055
The Influence of Default Options in Advance Directives
NCT01346176
Neural Response to Eating and Weight Status
NCT01228097
RCT to Examine the Effects of Scanning
NCT01804621
Effectiveness of Cognitive Processing Therapy in Pregnant Women With a History of Pregnancy Loss/Complication
NCT01277354
CART19 to Treat B-Cell Leukemia or Lymphoma That Are Resistant or Refractory to Chemotherapy
NCT01029366
Evaluation of Panel Reactive Antibody in Children Following Stage I Palliation for Hypoplastic Left Heart Syndrome
NCT01135485
Nicotine and Brain Imaging Research Study
NCT01227343
Long Term Chamomile Therapy for Anxiety
NCT01072344
Study of Ambrisentan With Antifibrotic Agent Combination Therapy in Diffuse Systemic Sclerosis
NCT01093885
Behavioral Economics and Food Choice
NCT01061905
Effects of Nicotine on Brain Opioid Receptors
NCT01040338
A Prospective, Cohort Study of Hyperpolarized 3He MRI in Chronic Obstructive Pulmonary Disease
NCT02734368
Desensitization With Belimumab in Sensitized Patients Awaiting Kidney Transplant
NCT01025193
Neural Substrates in Nicotine Withdrawal
NCT01001520
Fenofibrate and Omega-3 Fatty Acid Modulation of Endotoxemia
NCT01048502
To Learn How Bone Structure and Bone Mass Change After Long-term PPI Use
NCT01306799
Brain Imaging and Treatment Studies of the Night Eating Syndrome
NCT01401595
H1N1 Influenza Vaccine Immunogenicity in HIV-1 Infected Patients
NCT01111162
Observational Study of Control Participants for the MAPP Research Network
NCT01098292
Chronic Pelvic Pain Study of Individuals With Diagnoses or Symptoms of Interstitial Cystitis and/ or Chronic Prostatitis
NCT01098279
Neurobehavioral Effects of Partial Sleep Deprivation
NCT02128737
BMS Reverse Cholesterol Transport (RCT) Study
NCT01031862
Redirected High Affinity Gag-Specific Autologous T Cells for HIV Gene Therapy
NCT00991224
The Testosterone Trials in Older Men
NCT00799617
Naltrexone for Impulse Control Disorders in Parkinson's Disease
NCT01052831
Placental Growth and Adverse Pregnancy Outcomes
NCT01669525
Reverse Cholesterol Transport (RCT) Study
NCT01031758
Direct Measurements of Cervical Remodeling for Predicting Preterm Birth
NCT01175551
Effectiveness of Enhanced Treatments for Drug Dependence
NCT01153477
The Effect of a Planning Prompt on Seasonal Influenza Vaccination Rates
NCT01207232
Randomized Trial of Interventions to Improve Warfarin Adherence
NCT00904982
Patent Ductus Arteriosus (PDA) Screening Trial
NCT01031316
Phase Distribution
| Phase | Trial count |
|---|---|
| Phase 1 | 182 |
| Phase 2 | 157 |
| Phase 3 | 43 |
| Phase 4 | 87 |
Therapeutic Areas
What is open in the University of Pennsylvania pipeline
199 recruiting of 1,423 indexed (14% open); 982 completed (69%).
Phase mix: 130 late (III/IV) vs 339 early (I/II) (early-phase heavy).
Top condition: Obesity (17 trials), 9 others listed.
How open-pipeline share is computed
Recruiting share is recruiting_count divided by trial_count for this sponsor in the public registry export. Status can change between pulls; treat the figure as a research-attention snapshot, not product availability.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page aggregates every registered trial from this sponsor, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.